Latest News
Grain and energy shipments drove $4.8 billion revenue with $100 million in productivity savings.
Via The Motley Fool · July 24, 2026
Net income jumped 21% as adjusted EBITDA reached record levels.
Via The Motley Fool · July 24, 2026
Higher-acuity shift drives guidance hikes across revenue and cash flow.
Via The Motley Fool · July 24, 2026
Non-bank businesses tripled contribution as quarterly net income surged 66%.
Via The Motley Fool · July 24, 2026
Net income surged 15.4% despite margin compression and flat loan balances.
Via The Motley Fool · July 24, 2026
Brookfield Infrastructure Partners is yielding a generous 4.4% as it benefits from strong growth and demand for its infrastructure assets.
Via The Motley Fool · July 24, 2026
These Canadian stocks distribute dividends on a monthly basis and have reliable payouts, making them ideal investments for steady cash.
Via The Motley Fool · July 24, 2026
Investors eagerly sold out of software titles.
Via The Motley Fool · July 24, 2026
This dividend stock with a current yield of 4.4% is defensive and has major growth potential, making it the perfect stock to buy on the dip.
Via The Motley Fool · July 24, 2026
The average Canadian TFSA balance at age 50 may be lower than expected. Here’s how investors can boost their savings.
Via The Motley Fool · July 24, 2026
It posted an impressive quarterly earnings report.
Via The Motley Fool · July 24, 2026
Starting early and adding funds consistently is a recipe for success.
Via The Motley Fool · July 24, 2026
These two Canadian monthly dividend stocks could help turn a $30,000 TFSA into a steady stream of tax-free income while offering room for long-term growth.
Via The Motley Fool · July 24, 2026
Two TSX stocks could turn a record-setting market rally into profits from trading activity and jet deliveries.
Via The Motley Fool · July 24, 2026
Food safety concerns negatively affected sentiment on the company.
Via The Motley Fool · July 24, 2026
The popular altcoin could become an AI story.
Via The Motley Fool · July 24, 2026
Could Moderna be the next big opportunity in biotech? Join our experts as they dissect the company's strengths and weaknesses, revealing insights that could shape your investment strategy.
Via The Motley Fool · July 24, 2026
The specialty financial services company posted its first quarterly earnings report of fiscal 2027.
Via The Motley Fool · July 24, 2026
Here's how a $25,000 TFSA portfolio can become $942 per year of steadily growing tax-free passive income.
Via The Motley Fool · July 24, 2026
The market and the covering analysts are more than $130 apart on this stock.
Via The Motley Fool · July 24, 2026
The company's financial results look much better than its stock performance this year suggests at first.
Via The Motley Fool · July 24, 2026
The idea of combining the two companies is no longer a fan theory. It came up on an earnings call, and the CEO didn't say no.
Via The Motley Fool · July 24, 2026
An analyst initiated coverage of the biotech with a buy recommendation.
Via The Motley Fool · July 24, 2026
Today, July 24, 2026, shares fell almost 8% as strong premarket momentum evaporated as investors refocused on increasing capex plans.
Via The Motley Fool · July 24, 2026
Despite ongoing concerns about inflation, high living costs and economic uncertainty, many Americans are feeling better about their finances than they did a year ago, according to Northwestern Mutual’s 2026 Planning
Via Benzinga · July 24, 2026